Recent Finacing
Recent Raise
Tessera Therapeutics develops a Gene Writing platform that programs Mobile Genetic Elements to insert, delete, or rewrite DNA—including base-to-base changes and entire genes—via RNA delivery without double-strand breaks.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Tessera Therapeutics.
